Pharmaceutical Accountability
The article connects pharmaceutical political influence to resistance against Medicare drug price negotiation. Pharmaceutical fines may be treated as a cost of doing business when profits remain larger. The article argues that pharmaceutic…
1 sources - 5 claims
The article connects pharmaceutical political influence to resistance against Medicare drug price negotiation. Pharmaceutical fines may be treated as a cost of doing business when profits remain larger. The article argues that pharmaceutical lobbying power protects the existing system. The article argues that current penalties do not adequately deter pharmaceutical misconduct. Criminal liability for senior executives is described as rare even when companies commit felonies or many people are harmed.